FDA agrees to review Moderna’s mRNA flu vaccine following initial refusal

(NaturalNews) The FDA initially refused to review Moderna’s experimental mRNA flu vaccine due to concerns over trial design but reversed its decision days later…
Updated: February 21, 2026 — 6:13 am